Tonix Pharma Stock Price (NASDAQ:TNXP)

Add to My Stocks
$0.68 $0.06 (9.68%) TNXP stock closing price Sep 18, 2018 (Closing)
Prev Close* : $0.62
Market Cap:
Day Low: $0.66
52 Week Low: $0.62
Open: $0.74
Volume: -
Day High: $0.76
52 Week High: $5.11

Latest Stock Market News

Latest Articles

Tonix Pharma News - From Partners

TNXP Stockcharts

View TNXP PE ratio, PS ratio stocks charts and compare with peers.
TNXP Chart
Note: Compare Tonix Pharma stock price history with the index and industry peers.

Tonix Pharma Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Tonix Pharma Returns

(return on equity)

Tonix Pharma Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

TNXP Industry Peers

Company Price Change (%)
Ritter Pharma (RTTR)1.690.02 (1.17%)
Axm Pharma (AXMP)00 (0%)
Flexion Therapeutics (FLXN)19.80.07 (0.35%)
Savient Pharma (SVNTQ)00 (0%)
Radius Health (RDUS)17.510.27 (1.52%)
Unigene Laboratories (UGNEQ)00 (0%)
Eli Lilly (LLY)106.881.17 (1.11%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Tonix Pharmaceuticals Holding Corp. Stock News - Partner Headlines

Tonix Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-21.12M-38.84M-48.05M-27.61M-10.89M
Total Operating Expense21.28M38.96M48.15M27.64M10.88M
View Tonix Pharma income statement
balance sheet20172016201520142013
Total Assets26.75M27.51M47.01M39.54M8.73M
Total Liabilities2.13M2.14M6.75M3.45M2.22M
Shareholders Equity24.61M25.36M40.26M36.09M6.51M
View Tonix Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities--2.07M-1.04M-
Net Cash from (used by) Operating Activities-19.12M-37.31M-42.52M-22.84M-8.51M
Increase (Decrease) in Prop Plant And Equipment-0.01M-0.06M-0.11M-0.31M-0.01M
View Tonix Pharma cash flow statement

Tonix Pharma Stock Message Board

Tonix Pharma stock gained 9.68%, and the last close price as of Sep 18, 2018 is $0.68 for TNXP stock. Looking at Tonix Pharma market capitalization, which currently stands at $6.2M, we can say that TNXP stock is a Nano Cap stock. Tonix Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

For recognizing and analyzing the real performance of Tonix Pharma stock, it is a standard practise to adjust historical stock prices to remove gaps caused by stock splits, dividends and distributions. 429,513 shares were traded with a closing stock price of $0.68 as of Sep 18, 2018, as can be seen from Tonix Pharma stock quote. One can view Tonix Pharma stock chart to follow the stock price trend. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Tonix Pharma dividend per share was 0.00 during the last quarter. Tonix Pharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.